Evidence map›Paper›PMID 38469975›Full record

ArticleEuropean journal of neurology2024

Distinct neural signatures of pulvinar in C9orf72 amyotrophic lateral sclerosis mutation carriers and noncarriers.

Anna Nigri, Mario Stanziano, Davide Fedeli, Umberto Manera, Stefania Ferraro, Jean Paul Medina Carrion, Sara Palermo, Laura Lequio, Federica Denegri, Federica Agosta and 10 more

Abstract read
In one paragraph

Article in European journal of neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Eagle eyes on the human brain and beyond: PET at ultra-high spatial resolution.European journal of nuclear medicine and molecular imaging · 2026
    Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Anna NigriNeuroradiology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.ORCID 0000-0002-1197-5458
Mario StanzianoNeuroradiology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Davide FedeliNeuroradiology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Umberto ManeraALS Centre, "Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.ORCID 0000-0002-9995-8133
Stefania FerraroNeuroradiology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Jean Paul Medina CarrionNeuroradiology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.ORCID 0000-0002-6450-0202
Sara PalermoNeuroradiology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Laura LequioNeuroradiology Unit, CTO Hospital, AOU Città della Salute e della Scienza di Torino, Turin, Italy.
Federica DenegriNeuroradiology Unit, CTO Hospital, AOU Città della Salute e della Scienza di Torino, Turin, Italy.
Federica AgostaNeuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Edoardo Gioele SpinelliNeuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Massimo FilippiNeuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.ORCID 0000-0002-5485-0479
Marina GrisoliNeuroradiology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Maria Consuelo ValentiniNeuroradiology Unit, CTO Hospital, AOU Città della Salute e della Scienza di Torino, Turin, Italy.
Filippo De MatteiALS Centre, "Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.
Antonio CanosaALS Centre, "Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.
Andrea CalvoALS Centre, "Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.ORCID 0000-0002-5122-7243
Adriano ChiòALS Centre, "Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.
Maria Grazia BruzzoneNeuroradiology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Cristina MogliaALS Centre, "Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.ORCID 0000-0001-7377-7222

Funding

European Commission's Health Seventh Framework Programme 259867European Commission's Health Seventh Framework Programme FP7/2007-2013Ministero della Salute GR-2019-12371291Ministero della Salute RF-2016-02362405Ministero della Salute RRCMinistero dell'Università e della Ricerca 2017SNW5MB
6 · The paper itself

Abstract

background and purposeThalamic alterations have been reported as a major feature in presymptomatic and symptomatic patients carrying the C9orf72 mutation across the frontotemporal dementia-amyotrophic lateral sclerosis (ALS) spectrum. Specifically, the pulvinar, a high-order thalamic nucleus and timekeeper for large-scale cortical networks, has been hypothesized to be involved in C9orf72-related neurodegenerative diseases. We investigated whether pulvinar volume can be useful for differential diagnosis in ALS C9orf72 mutation carriers and noncarriers and how underlying functional connectivity changes affect this region.

methodsWe studied 19 ALS C9orf72 mutation carriers (ALSC9+) accurately matched with wild-type ALS (ALSC9-) and ALS mimic (ALSmimic) patients using structural and resting-state functional magnetic resonance imaging data. Pulvinar volume was computed using automatic segmentation. Seed-to-voxel functional connectivity analyses were performed using seeds from a pulvinar functional parcellation.

resultsPulvinar structural integrity had high discriminative values for ALSC9+ patients compared to ALSmimic (area under the curve [AUC] = 0.86) and ALSC9- (AUC = 0.77) patients, yielding a volume cutpoint of approximately 0.23%. Compared to ALSmimic, ALSC9- showed increased anterior, inferior, and lateral pulvinar connections with bilateral occipital-temporal-parietal regions, whereas ALSC9+ showed no differences. ALSC9+ patients when compared to ALSC9- patients showed reduced pulvinar-occipital connectivity for anterior and inferior pulvinar seeds.

conclusionsPulvinar volume could be a differential biomarker closely related to the C9orf72 mutation. A pulvinar-cortical circuit dysfunction might play a critical role in disease progression and development, in both the genetic phenotype and ALS wild-type patients.

Indexed as

Amyotrophic Lateral SclerosisC9orf72 ProteinMagnetic Resonance ImagingMutationPulvinarAgedFemaleFrontotemporal DementiaHeterozygoteHumansMaleMiddle AgedC9orf72 ProteinC9orf72 protein, humanamyotrophic lateral sclerosisC9orf72 mutationfMRIMRIpulvinar

Identifiers

PMID38469975
PMCPMC11235848

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.